A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

NCT02316353 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema Types I and II

Interventions

BIOLOGICAL: C1-esterase inhibitor

Sponsor

CSL Behring